Zhi Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhi Chen has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Chaofan Li
Academy of Military Medical Sciences
2 shared publicationsJinwen Su
ICU, Tuberculosis Department 8th Medical Center of Chinese PLA General Hospital Tuberculosis Research Institute Beijing China
2 shared publicationsLiang Yue
Academy of Military Medical Sciences
2 shared publicationsPengfei Zhong
Academy of Military Medical Sciences
2 shared publications- Yingxia Tan
Academy of Military Medical Sciences Beijing China
2 shared publications Zhimin Yun
Academy of Military Medical Sciences
2 shared publications
Latest Publications
- Open Access
- 10 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16
Human lung organoids model for assessing host response to Mycobacterium tuberculosis infection
Introduction: Airway and alveolar epithelial cells serve as the primary defense in the lower respiratory tract, yet their exact role in Mycobacterium tuberculosis (Mtb) infection is incompletely understood. Given that Mtb is a human-restricted pathogen, a representative human model is required. Lung organoids (LOs), which are composed of various epithelial cells, mesenchymal cells, and extracellular matrix, facilitate the investigation of bacterial infections. Methods: In this study, we established an Mtb infection model using human induced pluripotent stem cells (iPSCs)-derived LOs. Results: Prolonged infection led to the gradual invasion of Mtb from the periphery to the interior of the organoid, leading to decreased viability and the induction of fibrotic responses. Transcriptomic and protein analyses suggest that Mtb infection triggered a TLR4/NF-κB-associated inflammatory response. Additionally, the elevation of antimicrobial peptides and the release of diverse pro-inflammatory cytokines and chemokines were noted in the infected LOs. Conclusion: These findings emphasize the potential role of LOs in host defense and demonstrate that the Mtb -infected lung organoid model provides a novel platform for elucidating the role of pulmonary structural cells in tuberculosis pathogenesis. Furthermore, this model opens new avenues for the development of molecular therapeutic strategies.
- 10 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16
Open AccessHuman lung organoids model for assessing host response to Mycobacterium tuberculosis infection
Introduction: Airway and alveolar epithelial cells serve as the primary defense in the lower respiratory tract, yet their exact role in Mycobacterium tuberculosis (Mtb) infection is incompletely understood. Given that Mtb is a human-restricted pathogen, a representative human model is required. Lung organoids (LOs), which are composed of various epithelial cells, mesenchymal cells, and extracellular matrix, facilitate the investigation of bacterial infections. Methods: In this study, we established an Mtb infection model using human induced pluripotent stem cells (iPSCs)-derived LOs. Results: Prolonged infection led to the gradual invasion of Mtb from the periphery to the interior of the organoid, leading to decreased viability and the induction of fibrotic responses. Transcriptomic and protein analyses suggest that Mtb infection triggered a TLR4/NF-κB-associated inflammatory response. Additionally, the elevation of antimicrobial peptides and the release of diverse pro-inflammatory cytokines and chemokines were noted in the infected LOs. Conclusion: These findings emphasize the potential role of LOs in host defense and demonstrate that the Mtb -infected lung organoid model provides a novel platform for elucidating the role of pulmonary structural cells in tuberculosis pathogenesis. Furthermore, this model opens new avenues for the development of molecular therapeutic strategies.
- Open Access
- 6 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Evaluation of TST/C-TST combination for latent tuberculosis infection screening: diagnostic performance and cost-effectiveness compared to TST/IGRAs
The interferon-gamma release assays (IGRAs) are characterized by their complexity and reliance on specific instrumentation. The recombinant Mycobacterium t
- 6 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessEvaluation of TST/C-TST combination for latent tuberculosis infection screening: diagnostic performance and cost-effectiveness compared to TST/IGRAs
The interferon-gamma release assays (IGRAs) are characterized by their complexity and reliance on specific instrumentation. The recombinant Mycobacterium t
- Open Access
- 29 May 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (6)
Assessing Causality Between Endocrine, Nutritional, and Metabolic Disease and Pulmonary Tuberculosis: A Mendelian Randomization Study
Background and Aims: Observational studies frequently report co‐occurrence between endocrine, nutritional, and metabolic disease (ENMD) and pulmonary tuberculosis (PTB). However, the causal properties between them remain poorly defined. Our aim in this study was to investigate the causal effect of ENMD on PTB using Mendelian randomization analysis. Methods: We obtained single nucleotide polymorphisms linked to ENMD, ENMD‐related diseases, and clinical features, as well as PTB, from the IEU OpenGWAS project. Inverse variance weighting was used as the primary analytical method, complemented by Weighted median and MR‐Egger regression to assess their causal relationship. Heterogeneity and horizontal pleiotropy were assessed using Cochran's Q test and MR regression intercepts. The robustness of the results is evaluated by sensitivity analysis leave‐one‐out and MR‐PRESSO. Results: The inverse variance weighting analyses indicated that ENMD significantly increased the risk of PTB (OR = 1.41, 95% CI: 1.18–1.68, p < 0.001) after removing outliers. Interestingly, at the genetic level of European ancestry, there is no evidence of increased risk of PTB with T2DM (OR = 1.05, 95% CI: 0.99–1.12, p = 0.10), whereas high cholesterol (OR = 0.41, 95% CI: 0.22–0.79, p < 0.05), BMI (OR = 0.78, 95% CI: 0.69–0.88, p < 0.001) was negatively correlated with the risk of PTB, and LDL‐c showed a weak inverse correlation with PTB (OR = 0.90, 95% CI: 0.81–0.99, p = 0.03). Sensitivity analyses confirmed the robustness of these findings. Conclusion: This MR study provides novel genetic evidence that ENMD significantly elevates PTB risk. Notably, high cholesterol, BMI, and LDL‐c exhibit protective effects against PTB at the genetic level in European ancestry, while T2DM shows no causal association. These findings highlight the complex role of metabolic factors in tuberculosis susceptibility and suggest potential biological mechanisms linking metabolic dysregulation to PTB pathogenesis.
- 29 May 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (6)
Open AccessAssessing Causality Between Endocrine, Nutritional, and Metabolic Disease and Pulmonary Tuberculosis: A Mendelian Randomization Study
Background and Aims: Observational studies frequently report co‐occurrence between endocrine, nutritional, and metabolic disease (ENMD) and pulmonary tuberculosis (PTB). However, the causal properties between them remain poorly defined. Our aim in this study was to investigate the causal effect of ENMD on PTB using Mendelian randomization analysis. Methods: We obtained single nucleotide polymorphisms linked to ENMD, ENMD‐related diseases, and clinical features, as well as PTB, from the IEU OpenGWAS project. Inverse variance weighting was used as the primary analytical method, complemented by Weighted median and MR‐Egger regression to assess their causal relationship. Heterogeneity and horizontal pleiotropy were assessed using Cochran's Q test and MR regression intercepts. The robustness of the results is evaluated by sensitivity analysis leave‐one‐out and MR‐PRESSO. Results: The inverse variance weighting analyses indicated that ENMD significantly increased the risk of PTB (OR = 1.41, 95% CI: 1.18–1.68, p < 0.001) after removing outliers. Interestingly, at the genetic level of European ancestry, there is no evidence of increased risk of PTB with T2DM (OR = 1.05, 95% CI: 0.99–1.12, p = 0.10), whereas high cholesterol (OR = 0.41, 95% CI: 0.22–0.79, p < 0.05), BMI (OR = 0.78, 95% CI: 0.69–0.88, p < 0.001) was negatively correlated with the risk of PTB, and LDL‐c showed a weak inverse correlation with PTB (OR = 0.90, 95% CI: 0.81–0.99, p = 0.03). Sensitivity analyses confirmed the robustness of these findings. Conclusion: This MR study provides novel genetic evidence that ENMD significantly elevates PTB risk. Notably, high cholesterol, BMI, and LDL‐c exhibit protective effects against PTB at the genetic level in European ancestry, while T2DM shows no causal association. These findings highlight the complex role of metabolic factors in tuberculosis susceptibility and suggest potential biological mechanisms linking metabolic dysregulation to PTB pathogenesis.
- Open Access
- 10 June 2024
- Published by Springer Nature in BMC Neurology
- Vol. 24 (1) , 1-14
Efficacy and safety of intrathecal dexamethasone combined with isoniazid in the treatment of tuberculous meningitis: a meta-analysis
Background: The treatment regimen for tuberculous meningitis (TBM) remains unclear and requires optimization. There are some reports on successful adjunct intrathecal dexamethasone and isoniazid (IDI) treatment strategies for TBM, however, there is equivocal evidence on their efficacy and safety. Methods: A comprehensive search of English and Chinese databases was conducted from inception to February 2024. A meta-analysis was performed on randomized controlled trials (RCTs) estimating the effects of adjunct IDI on conventional anti-TB (C anti-TB) treatments or C anti-TB alone. Efficacy, adverse reaction rate, cerebrospinal fluid (CSF) leukocytes, and CSF protein were used as primary outcome indicators. CSF glucose, CSF chlorides, CSF pressure, recovery time for laboratory indicators and recovery time for clinical symptoms were used as secondary outcome indicators. Results: A total of 17 studies involving 1360 (IDI group vs. C anti-TB group: 392 vs. 372; higher-dose IDI group vs. lower-dose IDI group: 319 vs. 277) patients were included in our analysis. Efficacy was significantly higher (RR 1.3, 95% CI 1.2-1.4, P < 0.001) and adverse reaction rate was significantly lower in the IDI groups (RR 0.59, 95% CI 0.37-0.92, P = 0.021). Furthermore, CSF leukocytes (WMD - 29.33, 95% CI [- 40.64 to-18.02], P < 0.001) and CSF protein (WMD - 0.79, 95%CI [-0.96 to-0.61], P < 0.001) were significantly lower in the IDI groups. Recovery time indicators were all shorter in the IDI groups, fever (SMD - 2.45, 95% CI [-3.55 to-1.35], P < 0.001), coma (SMD-3.75, 95% CI [-4.33 to-3.17], P < 0.001), and headache (SMD - 3.06, 95% CI [- 4.05 to-2.07], P < 0.001), respectively. Higher-dose IDI was more effective than lower-dose IDI (RR 1.23, 95% CI 1.14-1.33, P < 0.001), with no significant difference in adverse reaction rate between the two (RR 0.82, 95%CI 0.43–1.56, P = 0.544). Conclusion: Adjunct IDI with C anti-TB can enhance therapeutic outcomes and reduce adverse reaction rate in adult TBM patients, with higher-dose IDI showing superior efficacy. These findings highlight the potential of IDI as an adjunctive therapy in TBM management. However, more high-quality RCTs from more regions should be conducted to support our results. Trial registration: Retrospectively registered in PROSPERO https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023388860.
- 10 June 2024
- Published by Springer Nature in BMC Neurology
- Vol. 24 (1) , 1-14
Open AccessEfficacy and safety of intrathecal dexamethasone combined with isoniazid in the treatment of tuberculous meningitis: a meta-analysis
Background: The treatment regimen for tuberculous meningitis (TBM) remains unclear and requires optimization. There are some reports on successful adjunct intrathecal dexamethasone and isoniazid (IDI) treatment strategies for TBM, however, there is equivocal evidence on their efficacy and safety. Methods: A comprehensive search of English and Chinese databases was conducted from inception to February 2024. A meta-analysis was performed on randomized controlled trials (RCTs) estimating the effects of adjunct IDI on conventional anti-TB (C anti-TB) treatments or C anti-TB alone. Efficacy, adverse reaction rate, cerebrospinal fluid (CSF) leukocytes, and CSF protein were used as primary outcome indicators. CSF glucose, CSF chlorides, CSF pressure, recovery time for laboratory indicators and recovery time for clinical symptoms were used as secondary outcome indicators. Results: A total of 17 studies involving 1360 (IDI group vs. C anti-TB group: 392 vs. 372; higher-dose IDI group vs. lower-dose IDI group: 319 vs. 277) patients were included in our analysis. Efficacy was significantly higher (RR 1.3, 95% CI 1.2-1.4, P < 0.001) and adverse reaction rate was significantly lower in the IDI groups (RR 0.59, 95% CI 0.37-0.92, P = 0.021). Furthermore, CSF leukocytes (WMD - 29.33, 95% CI [- 40.64 to-18.02], P < 0.001) and CSF protein (WMD - 0.79, 95%CI [-0.96 to-0.61], P < 0.001) were significantly lower in the IDI groups. Recovery time indicators were all shorter in the IDI groups, fever (SMD - 2.45, 95% CI [-3.55 to-1.35], P < 0.001), coma (SMD-3.75, 95% CI [-4.33 to-3.17], P < 0.001), and headache (SMD - 3.06, 95% CI [- 4.05 to-2.07], P < 0.001), respectively. Higher-dose IDI was more effective than lower-dose IDI (RR 1.23, 95% CI 1.14-1.33, P < 0.001), with no significant difference in adverse reaction rate between the two (RR 0.82, 95%CI 0.43–1.56, P = 0.544). Conclusion: Adjunct IDI with C anti-TB can enhance therapeutic outcomes and reduce adverse reaction rate in adult TBM patients, with higher-dose IDI showing superior efficacy. These findings highlight the potential of IDI as an adjunctive therapy in TBM management. However, more high-quality RCTs from more regions should be conducted to support our results. Trial registration: Retrospectively registered in PROSPERO https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023388860.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (16) , 6185-6201
Spatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum
Granulomas are a key pathological feature of tuberculosis (TB), characterized by cell heterogeneity, spatial composition, and cellular interactions, which play crucial roles in granuloma progression and host prognosis. This study aims to analyze the transcriptome profiles of cell populations based on their spatial location and to understand the core transcriptome characteristics of granuloma formation and development.
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (16) , 6185-6201
Top Cited PapersOpen AccessSpatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum
Granulomas are a key pathological feature of tuberculosis (TB), characterized by cell heterogeneity, spatial composition, and cellular interactions, which play crucial roles in granuloma progression and host prognosis. This study aims to analyze the transcriptome profiles of cell populations based on their spatial location and to understand the core transcriptome characteristics of granuloma formation and development.
- 1 July 2015
- Published by Elsevier in Tuberculosis
- Vol. 95 (4) , 490-496
Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis
- 1 July 2015
- Published by Elsevier in Tuberculosis
- Vol. 95 (4) , 490-496
Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis
- Open Access
- 8 May 2015
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 15 (1) , 1-10
Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis
Previous studies indicated that the single nucleotide polymorphisms (SNPs) in TLR9 gene might be associated with Tuberculosis (TB) risk. However, the results are inconsistent and inconclusive. 1745 articles from four databases were involved in our study. A meta-analysis on the associations between the seven polymorphisms and TB risk was carried out by comparison using different genetic models. In this systematic review 8 studies from seven English articles were analyzed. Our results showed that rs352139 is significantly associated with TB risk (AA vs. AG, OR 0.77, 95% CI 0.65-0.92, P = 0.004). In the ethnic subgroup analysis, Indonesians with AA genotype had a decreased susceptibility while Mexicans with GG allele had an increased risk. The meta-analysis indicated that rs352139 polymorphism might be associated with decreased TB risk in Indonesians whereas increased risk in Mexicans. Whether the observed association was due to causal effect needs to be further studied.
- 8 May 2015
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 15 (1) , 1-10
Open AccessAssociation between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis
Previous studies indicated that the single nucleotide polymorphisms (SNPs) in TLR9 gene might be associated with Tuberculosis (TB) risk. However, the results are inconsistent and inconclusive. 1745 articles from four databases were involved in our study. A meta-analysis on the associations between the seven polymorphisms and TB risk was carried out by comparison using different genetic models. In this systematic review 8 studies from seven English articles were analyzed. Our results showed that rs352139 is significantly associated with TB risk (AA vs. AG, OR 0.77, 95% CI 0.65-0.92, P = 0.004). In the ethnic subgroup analysis, Indonesians with AA genotype had a decreased susceptibility while Mexicans with GG allele had an increased risk. The meta-analysis indicated that rs352139 polymorphism might be associated with decreased TB risk in Indonesians whereas increased risk in Mexicans. Whether the observed association was due to causal effect needs to be further studied.